1[1]Levine C, Hiasa H, Marians K. DNA gyrase and topoisomerase Ⅳ: biochemical activities, physiological roles during chromosome replication, and drug sensitivities [J]. Biochim Biophys Acta,1998,140(3): 29 - 43.
2[2]Schaeffer AJ. The expanding role of fluoroquinolones[ J]. Am J Med,2002,8(7): 113- 115.
3[3]EomJS, Wang H, Sohn JW, et al. Clinical and molecular epidemidogy of quinolone- resistant Escherichia coli isolated from urinary tract infection [ J]. Microb Drug Resist, 2002, 8 (3): 227 -234.
4[4]Yushida H, Bogaki M, Nakamura M,et al. Quinolone resistance -determining region in the DNA gyrase gyrA gene of Escherichia coli [J]. Antimicrob Agents Chemother, 1990;34(6): 12711272.
5[5]Ferrero L, Cameron B, Crouzet J. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus [ J ]. Antimicrob Agents Chemother,1995,39(7): 1554 - 1558.
6[6]Ng EY, Trucksis M, Hooper DC. Quinolone resistance mutations in topoisomerase Ⅳ: relationship of the flqA locus and genetic evidence that topoisomerase Ⅳ is the primary target and DNA gyrase the secondary target of fluoroquinolones in Staphylococcus aureus [ J]. Antimicrob Agents Chemother, 1996,40(8 ): 1881 -1888.
7[7]Willmott CJ, Maxwell A. A sigle point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex[ J ]. Antimicrob Agents Chemother, 1993,37(1):126- 127.
8[8]Horii T, Suzuki Y, Monji A, Morita M,et al. Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus : effects of the mutations on fluoroquinolone MICs[J]. Diagn Microbiol Infect Dis. 2003 Jun;46(2): 139 - 45.
9[9]Ince D, Hooper DC. Mechanism and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interaction[J]: Antimicrob Agents Chemother,2000,44(12) :3344 - 3350.
10[10]Schmitz FJ,Jones ME,Hofmann B,et al. Characterization of gr1A,grlB,gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC[ J ]. Antimicrob Agents Chemother, 1998,42 (5): 1249 -1252.
4[2]MELO-CRISTINO J.Antimicrobial resistance in Staphylococci and Enterococci in 10 Protuguese hospitals in 1996 and 199-7.POSGAR,Protuguese Study Group of Antimicrobial Resistance[J].Microb Drug Resist,1998,4(4):19-24.
